Physician profile
Harold Neitzschman
NPI 1942357900
$467.08
in general payments reported to CMS, 2019-2025
8 companies · $58.37 in 2025
The $58.37 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $12.00 · 2021: $44.97 · 2022: $27.15 · 2023: $63.25 · 2024: $70.54 · 2025: $58.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182 · Education: $9.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.48 |
| Education | $9.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $152.19 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $138.27 | 2019 | |
| Urovant Sciences INC | $60.16 | 2021-2022 | |
| Boston Scientific Corporation | $33.92 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $30.29 | 2024 | |
| Travere Therapeutics, INC. | $24.51 | 2019-2025 | Thiola |
| Astellas Pharma US INC | $15.78 | 2019 | |
| Urogen Pharma, INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Neitzschman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.